Clinical Trials on HER2 Low Breast Carcinoma in India
Total 22 results
-
Dr Rajendra A. BadweTata Memorial HospitalRecruitingHER2 Positive Breast Cancer | Carcinoma Breast Stage IIndia
-
CelltrionNippon Kayaku Co., Ltd.CompletedHER2-positive Carcinoma of BreastItaly, South Africa, Mexico, Japan, Taiwan, Russian Federation, Philippines, Hungary, Romania, Spain, Bosnia and Herzegovina, India, Peru, Ukraine, Latvia, Argentina, Georgia, Belarus, Chile, France, Poland, Portugal
-
Sun Pharma Advanced Research Company LimitedTerminatedAdvanced Breast Cancer | HER2-negative Breast Cancer | Hormone Receptor-positive Breast CancerUnited States, India
-
PfizerCompletedBreast Cancer | Breast Neoplasms | Breast Tumors | Breast Carcinoma | Cancer of BreastIndia
-
Tata Medical CenterCompletedCarcinoma Breast Stage IVIndia
-
Hoffmann-La RocheCompletedHER2 Positive Breast Cancer, Metastatic Breast Cancer, Locally Advanced Breast CancerIndia
-
Tata Memorial CentreUnknown
-
Peregrine PharmaceuticalsCompletedCarcinoma Breast Stage IVIndia
-
International Agency for Research on CancerMalabar Cancer Care Society Kannur, India; Bhabha Atomic Research Centre (BARC)...RecruitingCarcinoma in Situ | Breast CancerIndia
-
Postgraduate Institute of Medical Education and...CompletedBreast Cancer | Adverse Effect of Radiation TherapyIndia
-
AstraZenecaDaiichi SankyoActive, not recruitingBreast Cancer | Breast Neoplasms | HER2-positive Early Breast CancerUnited States, Italy, Spain, Poland, Taiwan, Thailand, Canada, Germany, Korea, Republic of, Brazil, India, Japan, Peru, Philippines, China, Saudi Arabia, Russian Federation, Bulgaria
-
Tanvex BioPharma USA, Inc.CompletedBreast Cancer | Breast Neoplasms | HER2-positive Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Early-stage Breast CancerBelarus, Chile, Georgia, Hungary, India, Mexico, Peru, Philippines, Russian Federation, Ukraine
-
Tanvex BioPharma USA, Inc.CompletedBreast Cancer | Breast Neoplasms | HER2-positive Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast CancerBelarus, Chile, Georgia, Hungary, India, Mexico, Peru, Philippines, Russian Federation, Ukraine
-
AstraZenecaActive, not recruitingER-Positive HER2-Negative Breast CancerAustria, Belgium, France, Germany, Italy, United Kingdom, United States, Canada, India, Taiwan, Russian Federation, Korea, Republic of, Hungary, Japan, Mexico, Turkey, China, Malaysia, Spain, Czechia, Portugal, Poland, Norway, Bulgaria, Slovaki... and more
-
AstraZenecaDaiichi SankyoActive, not recruitingBreast Cancer; HER2-positive; MetastaticUnited States, Belgium, Canada, Denmark, Italy, Spain, Hungary, Taiwan, Turkey, France, Germany, Korea, Republic of, Brazil, India, Japan, Peru, Philippines, United Kingdom, China, South Africa, Israel, Russian Federation, Argentina, ... and more
-
Hoffmann-La RocheRecruitingEstrogen Receptor-Positive, HER2-Negative Advanced Breast CancerBelgium, Korea, Republic of, United States, Canada, China, Italy, France, Brazil, Australia, Argentina, Hong Kong, Portugal, Spain, Taiwan, Costa Rica, Israel, Thailand, Germany, New Zealand, Poland, Chile, Colombia, Guatemala, Hungary, Indi...
-
BiocadCompletedHuman Epithelial Receptor (HER)-2 Positive Breast CancerUkraine, Russian Federation, Belarus, India
-
SandozCompleted
-
AstraZenecaCompletedBreast Cancer | Ovarian CancerIndia
-
National Cancer Institute (NCI)CompletedCervical Cancer | Cervical Intraepithelial Neoplasia | HIV/AIDS | Biomarkers | HPVIndia
-
NICHD Global Network for Women's and Children's...RecruitingPregnancy Outcome Trends in Low-resource Geographic AreasUnited States, Pakistan, Zambia, Congo, The Democratic Republic of the, Guatemala, India, Bangladesh
-
AstraZenecaDaiichi Sankyo Co., Ltd.Active, not recruitingPart 1: Bladder, Biliary Tract, Cervical, Endometrial, Ovarian, Pancreatic Cancer, Rare Tumors, Any Tumor Type Excluding Breast, Gastric, Colorectal Cancer | Part 2: HER2 Expressing/Amplified Solid Tumors Excluding Breast, Gastric, Colorectal CancerBelgium, United States, Poland, India, Taiwan, Thailand, Korea, Republic of, Czechia, Russian Federation, United Kingdom, Spain, Australia, Canada, Italy, Netherlands